DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Capital and Codeine (Acetaminophen / Codeine Phosphate) - Published Studies


Published Studies Related to Capital and Codeine (Acetaminophen / Codeine)

Well-designed clinical trials related to Capital and Codeine (Acetaminophen / Codeine)

Economic evaluation of controlled-release oxycodone vs oxycodone-acetaminophen for osteoarthritis pain of the hip or knee. [2006.04]

Analgesic efficacy of rofecoxib compared with codeine/acetaminophen using a model of acute dental pain. [2005.10]

Well-designed clinical trials possibly related to Capital and Codeine (Acetaminophen / Codeine)

Liver cancer: effects, safety, and cost-effectiveness of controlled-release oxycodone for pain control after TACE. [2012]

Hospitalization costs of total knee arthroplasty with a continuous femoral nerve block provided only in the hospital versus on an ambulatory basis: a retrospective, case-control, cost-minimization analysis. [2007.01]

Postoperative pain management after craniotomy: evaluation and cost analysis. [2006.10]

Other research related to Capital and Codeine (Acetaminophen / Codeine)

Comparison of ibuprofen and acetaminophen with codeine following cosmetic facial surgery. [2009.10]

Codeine-acetaminophen versus nonsteroidal anti-inflammatory drugs in the treatment of post-abdominal surgery pain: a systematic review of randomized trials. [2009.08]

Other possibly related research studies

Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002. [2006.11]

Trends in controlled-release oxycodone (OxyContin) prescribing among Medicaid recipients in Kentucky, 1998-2002. [2006.06]

[Patterns of prescription and usage of triptans in Alsace (France): misuse is frequent and avoidable] [2006.03]

Prescribing Schedule 8 drugs. [2006.01]

Treatment of pain in juvenile idiopathic arthritis: a survey of pediatric rheumatologists. [2006.02.15]

Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004. [2005.10]

Opioid purchases and expenditure in nine western European countries: 'are we killing off morphine?'. [2005.04]

[Increasing importance of opioids in geriatrics] [2005.08]

Economic evaluation of Durogesic in moderate to severe, nonmalignant, chronic pain in Germany. [2006.12]

Controlled-release oxycodone admissions in public and private substance abuse treatment: associations with organizational characteristics. [2007]

Prescribing patterns and purchasing costs of long-acting opioids over nine years at an academic oncology hospital. [2007.08.01]

Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone. [2007.10]

Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States. [2007.08]

Short stay pyeloplasty: variables affecting pain and length of stay. [2008.04]

[Variable prescription of opioids to cancer patients in Norway] [2008.05.29]

Cost-effectiveness analysis of the analgesic therapy of postoperative pain. [2008.01]

Medicaid Prior Authorization and Controlled-Release Oxycodone. [2008.06]

Prevalence of alcohol and drugs among Norwegian motor vehicle drivers: a roadside survey. [2008.09]

Epidemiology of opioid pharmacy claims in the United States. [2008.05]

Risk evaluation and mitigation strategies for drugs with abuse liability: public interest, special interest, conflicts of interest, and the industry perspective. [2008.10]

Co-morbidity and utilization of medical services by pain patients receiving opioid medications: data from an insurance claims database. [2009.07]

Cost-effectiveness of strong opioids focussing on the long-term effects of opioid-related fractures: a model approach. [2009.07]

Prevalence of opioid dispensings and concurrent gastrointestinal medications in Quebec. [2008.09]

[Morphine or oxycodone tablets for pain?] [2010.08.12]

Costs of gastrointestinal events after outpatient opioid treatment for non-cancer pain. [2010.04]

[Cost-effective analysis of rotation from sustained-release morphine tablet to transdermal fentanyl of matrix type or sustained-release oxycodone tablet] [2009.12]

Trends in opioid consumption in the Nordic countries 2002-2006. [2009.10]

Economic evaluation of OROS hydromorphone for chronic pain: a Pan-European perspective. [2011.07]

A comparison of daily average consumption (DACON) of oxycodone and oxymorphone long-acting oral tablets. [2011.06]

Patterns of postoperative pain medication prescribing after invasive dental procedures. [2011.03]

Cost-effectiveness analysis of tapentadol immediate release for the treatment of acute pain. [2010.09]

The comparative safety of opioids for nonmalignant pain in older adults. [2010.12.13]

[The licit opioid consumption in Denmark]. [2010.11.15]

Hydrocodone: does it have a role in palliative care? [2010.07]

Clonidine as an adjunct to intravenous regional anesthesia: A randomized, double-blind, placebo-controlled dose ranging study. [2011.07]

Imputing at-work productivity loss using results of a randomized controlled trial comparing tapentadol extended release and oxycodone controlled release for osteoarthritis pain. [2012]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012